HHC ACO Inc., an Accountable Care Organization | NYC Health + Hospitals

COVID-19 ALERT: Find Community Testing Sites. Read the Travel Advisory. Learn more about NYC Test & Trace Corps.

HHC ACO Inc., an Accountable Care Organization

ACO Name and Location

HHC ACO Inc
Previous Names: N/A
7 Hanover Square, 9th Floor
New York, NY 10004

ACO Primary Contact

Primary Contact Name Matthew Siegler
Primary Contact Phone Number 212-788-3479
Primary Contact Email Address SieglerM@nychhc.org

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Downtown Bronx Medical Associates, P.C. Y
University Physicians of Brooklyn, Inc Y
New York City Health and Hospitals Corporation Y
Community Healthcare Network, Inc. Y
Harlem Medical Associates, P.C. Y
Metropolitan Medical Practice Plan, P.C. Y
Coney Island Medical Practice Plan, P.C. Y
Icahn School of Medicine at Mount Sinai (DBA: Mount Sinai Elmhurst Faculty Practice Group) Y

ACO governing body:

Member
Last Name First Name Title/Position
Member’s Voting Power – Expressed as a percentage or number Membership Type ACO Participant Legal Business Name/DBA, if Applicable
Katz Mitchell Chair
1 ACO Participant Representative New York City Health and Hospitals Corporation
Siegler Matthew CEO
1 ACO Participant Representative New York City Health and Hospitals Corporation
Kalkut Gary Vice President
1 ACO Participant Representative New York City Health and Hospitals Corporation
Ulberg, Jr. John E. Treasurer
1 ACO Participant Representative New York City Health and Hospitals Corporation
Rocha, Jr. Israel Secretary
1 ACO Participant Representative New York City Health and Hospitals Corporation
Peart Hyacinth Voting Member
1 Medicare Beneficiary Representative  
Cohen Andrea Voting Member
1 ACO Participant Representative New York City Health and Hospitals Corporation
Donnell Lori Voting Member
1 ACO Participant Representative University Physicians of Brooklyn, Inc.
Marcos Luis Voting Member
1 Other  
Moshirpur Jasmin Voting Member
1 ACO Participant Representative Mount Sinai Elmhurst Faculty Practice Group
Seigel Warren Voting Member
1 ACO Participant Representative Coney Island Medical Practice Plan, P.C.

Key ACO clinical and administrative leadership:

Matthew Siegler ACO Executive
David Stevens, MD Chief Medical Officer
Catherine Patsos, Esq. Compliance Officer
David Stevens, MD

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Governance Committee Mitchell Katz, MD, Board Chair
Clinical Leadership & Quality Assurance Committee David Stevens, MD, Chief Medical Officer
Audit Committee John Ulberg, MPH

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
  • Performance Year 2018, $2,967,275
  • Performance Year 2017, $2,182,360
  • Performance Year 2016, $1,586,859
  • First Agreement Period
  • Performance Year 2015, $6,052,364
  • Performance Year 2014, $2,644,605
  • Performance Year 2013, $3,639,766

Shared Savings Distribution

  • Second Agreement Period
  • Performance Year 2018
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 48%
  • Proportion of distribution to ACO participants: 52%
  • Performance Year 2017
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 57%
  • Proportion of distribution to ACO participants: 43%
  • Performance Year 2016
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 85%
  • Proportion of distribution to ACO participants: 15%
  • First Agreement Period
  • Performance Year 2015
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 20%
  • Proportion of distribution to ACO participants: 80%
  • Performance Year 2014
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 28%
  • Proportion of distribution to ACO participants: 72%
  • Performance Year 2013
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 36%
  • Proportion of distribution to ACO participants: 64%

Quality Performance Results

2018 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 78.17 86.14
ACO-2 CAHPS: How Well Your Providers Communicate 91.07 93.93
ACO-3 CAHPS: Patients’ Rating of Provider 90.53 92.45
ACO-4 CAHPS: Access to Specialists 75.65 81.50
ACO-5 CAHPS: Health Promotion and Education 67.14 59.26
ACO-6 CAHPS: Shared Decision Making 59.53 61.94
ACO-7 CAHPS: Health Status/Functional Status 71.42 73.35
ACO-34 CAHPS: Stewardship of Patient Resources 27.11 26.26
ACO-8 Risk Standardized, All Condition Readmission 15.39 14.98
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 18.71 18.59
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 46.51 37.01
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 103.97 76.75
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 75.42 59.00
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91) 1.79 1.98
ACO-11 Use of Certified EHR Technology 100.00 98.20
ACO-12 Medication Reconciliation Post-Discharge 79.58 85.91
ACO-13 Falls: Screening for Future Fall Risk 81.25 79.73
ACO-44 Use of Imaging Studies for Low Back Pain 80.00 64.36
ACO-14 Preventive Care and Screening: Influenza Immunization 76.23 72.71
ACO-15 Pneumonia Vaccination Status for Older Adults 84.58 75.97
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 82.72 76.83
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 87.18 72.81
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 87.70 66.74
ACO-19 Colorectal Cancer Screening 71.00 68.27
ACO-20 Breast Cancer Screening 75.67 71.96
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 92.37 81.47
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 19.09 15.51
ACO-41 Diabetes: Eye Exam 64.55 52.42
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 70.57 73.10
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 88.10 88.92

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.

Note: In the Quality Performance Results file(s) above, search for “HHC ACO Inc” to view the quality performance results. This ACO can also be found by using the ACO ID A1675 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.

WE ALWAYS PUT PATIENTS FIRST